Style | Citing Format |
---|---|
MLA | M Neissi MOSTAFA, et al.. "Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights." Asian Biomedicine, vol. 19, no. 3, 2025, pp. 154-163. |
APA | M Neissi MOSTAFA, Sk Almozani Sahar KAREEM, Ar Alzaalan Ayoob RADHI, NULL, M Sheikhhosseini MOTAHAREH, Ai Albadran Adnan ISSA, E Nekouei ELAHEH (2025). Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights. Asian Biomedicine, 19(3), 154-163. |
Chicago | M Neissi MOSTAFA, Sk Almozani Sahar KAREEM, Ar Alzaalan Ayoob RADHI, NULL, M Sheikhhosseini MOTAHAREH, Ai Albadran Adnan ISSA, E Nekouei ELAHEH. "Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights." Asian Biomedicine 19, no. 3 (2025): 154-163. |
Harvard | M Neissi MOSTAFA et al. (2025) 'Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights', Asian Biomedicine, 19(3), pp. 154-163. |
Vancouver | M Neissi MOSTAFA, Sk Almozani Sahar KAREEM, Ar Alzaalan Ayoob RADHI, NULL, M Sheikhhosseini MOTAHAREH, Ai Albadran Adnan ISSA, et al.. Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights. Asian Biomedicine. 2025;19(3):154-163. |
BibTex | @article{ author = {M Neissi MOSTAFA and Sk Almozani Sahar KAREEM and Ar Alzaalan Ayoob RADHI and NULL and M Sheikhhosseini MOTAHAREH and Ai Albadran Adnan ISSA and E Nekouei ELAHEH}, title = {Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights}, journal = {Asian Biomedicine}, volume = {19}, number = {3}, pages = {154-163}, year = {2025} } |
RIS | TY - JOUR AU - M Neissi MOSTAFA AU - Sk Almozani Sahar KAREEM AU - Ar Alzaalan Ayoob RADHI AU - NULL AU - M Sheikhhosseini MOTAHAREH AU - Ai Albadran Adnan ISSA AU - E Nekouei ELAHEH TI - Oculocutaneous Albinism in a Patient With an Oca2 Variant: Molecular and Clinical Insights JO - Asian Biomedicine VL - 19 IS - 3 SP - 154 EP - 163 PY - 2025 ER - |